TONY GEORGE: Open Payments
NPI 1235565862 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,830 in 133 payments from 20 companies in 2025. Trend: 2023 $677 · 2024 $2,636 · 2025 $2,830
Food & beverage: $2,830
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 15 | $487 |
| AstraZeneca Pharmaceuticals LP | 20 | $401 |
| GlaxoSmithKline, LLC. | 18 | $386 |
| GENZYME CORPORATION | 9 | $248 |
| Novartis Pharmaceuticals Corporation | 10 | $206 |
| ARS Pharmaceuticals Operations, Inc. | 9 | $170 |
| Amgen Inc. | 15 | $168 |
| Genentech USA, Inc. | 5 | $119 |
| Galderma Laboratories, L.P. | 5 | $96 |
| Incyte Corporation | 4 | $89 |
Products named: DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, XOLAIR, NEFFY, AYVAKIT, AIRSUPRA, NUCALA.
Industry payments across TX — which companies pay providers there.
